financetom
Business
financetom
/
Business
/
Okta Raises Full-Year Revenue Outlook Following Fiscal Fourth-Quarter Beat
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Okta Raises Full-Year Revenue Outlook Following Fiscal Fourth-Quarter Beat
Mar 4, 2025 4:03 AM

06:32 AM EST, 03/04/2025 (MT Newswires) -- Okta ( OKTA ) shares spiked early Tuesday as the company lifted its full-year revenue outlook and posted stronger-than-expected fiscal fourth-quarter results.

The cloud-based access management platform company now anticipates revenue to be in a range of $2.85 billion to $2.86 billion for fiscal 2026, representing annual growth of 9% to 10%, it said late Monday. During a third-quarter earnings call in December, Chief Financial Officer Brett Tighe said the company was estimating revenue of $2.77 billion to $2.78 billion, reflecting a year-over-year gain of 7%. The current consensus on FactSet is for $2.83 billion.

"We're taking a prudent approach to forward guidance that factors in our previously announced go to market specialization," Tighe said on a Monday conference call, according to a FactSet transcript. "We remain focused on reigniting growth and driving spend, efficiencies and cash flow."

Adjusted earnings are pegged to come in between $3.15 and $3.20 per share for the ongoing fiscal year, while the Street is looking for $3.11. In fiscal 2025, adjusted EPS soared to $2.81 from $1.60 in the previous fiscal year. The stock climbed 16% in the most recent premarket activity.

Last month, Okta ( OKTA ) disclosed in a regulatory filing with the Securities and Exchange Commission that it will lay off 180 employees, or 3% of its total workforce. The move was part of the company's ongoing assessment to optimize its cost structure and reallocate dollars and resources to growth priorities, Tighe said on the call.

Okta ( OKTA ) posted adjusted EPS of $0.78 for the quarter ended Jan. 31, up from $0.63 the year before, ahead of the average analyst estimate of $0.74. Revenue advanced 13% year over year to $682 million, topping the Street's view for $668.9 million. Subscription revenue inclined to $670 million from $591 million in the prior-year quarter.

Remaining performance obligations, or RPO, jumped 25% to $4.22 billion driven by an increase in weighted average term length for fourth-quarter deals, which "reached a multi-year high," Tighe told analysts. The company's bookings crossed $1 billion in total contract value for the first time during the quarter, Tighe said. Current RPO grew 15% to $2.25 billion.

For the current three-month period, Okta ( OKTA ) expects adjusted EPS of $0.76 to $0.77 on revenue of $678 million to $680 million. The market's current forecast is for non-GAAP EPS of $0.75 and sales of $676.9 million. The company expects to pay the cash impact of about $11 million related to last month's job cuts in the ongoing quarter, according to Tighe.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Telix To Acquire ARTMS Inc And Its Advanced Isotope Production Platform
BRIEF-Telix To Acquire ARTMS Inc And Its Advanced Isotope Production Platform
Mar 4, 2024
March 4 (Reuters) - Telix Pharmaceuticals Ltd ( TLPPF ): * TELIX TO ACQUIRE ARTMS, INC. AND ITS ADVANCED ISOTOPE PRODUCTION PLATFORM * TELIX PHARMACEUTICALS LTD ( TLPPF ) - ACQUISITION HAS POTENTIAL TO BE FINANCIALLY ACCRETIVE, ADD ADDITIONAL REVENUE * TELIX PHARMACEUTICALS LTD ( TLPPF ) - ACQUISITION HAS POTENTIAL TO HAVE POSITIVE IMPACT ON GROSS MARGINS FOR ILLUCCIX...
Balrampur Chini expects profit boost from higher cane availability
Balrampur Chini expects profit boost from higher cane availability
Nov 29, 2023
Balrampur Chini Mills is hopeful that better cane quality will mean better recoveries, more cane crushing, and improved realisations.
Tandem Diabetes Care Plans $250 Million Private Placement Notes -- Shares Decline After Hours
Tandem Diabetes Care Plans $250 Million Private Placement Notes -- Shares Decline After Hours
Mar 4, 2024
05:31 PM EST, 03/04/2024 (MT Newswires) -- Tandem Diabetes Care ( TNDM ) said Monday it plans a private placement of $250 million in principal amount of convertible notes due 2029. Initial purchasers will have the option to buy up to an additional $37.5 million principal amount of notes, according to the company. Net proceeds, along with cash at hand,...
PRESS DIGEST- Financial Times - March 5
PRESS DIGEST- Financial Times - March 5
Mar 4, 2024
March 5 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines - Cinven agrees to buy majority stake in fund administrator Alter Domus - Jeremy Hunt set to give motorists 5 bln pound tax break in the Budget - 'Erroneous' filings highlight flaws...
Copyright 2023-2026 - www.financetom.com All Rights Reserved